We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 251 results
  1. Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes

    Mutations in the Contactin-associated protein-like 2 ( CNTNAP2 ) gene are associated with autism spectrum disorder (ASD), and ectodomain shedding of...

    Qing Zhang, Mengen Xing, ... Weihong Song in Signal Transduction and Targeted Therapy
    Article Open access 01 March 2024
  2. Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease

    Early onset familial Alzheimer’s disease (FAD) with APP, PS1/2 (presenilins) mutation accounts for only a small portion of AD cases, and most are...

    Zhengjiang Qian, ZhiHao Wang, ... Keqiang Ye in Molecular Psychiatry
    Article Open access 24 April 2024
  3. An insight into Alzheimer’s disease and its on-setting novel genes

    According to the World Health Organisation, as of 2019, globally around 50 million people suffer from dementia, with approximately another 10 million...

    Jaanaky Vigneswaran, Sivaloganathan Anogh Muthukumar, ... Geetika Pant in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 29 November 2021
  4. CNTNAP2 intracellular domain (CICD) generated by γ-secretase cleavage improves autism-related behaviors

    As the most prevalent neurodevelopmental disorders in children, autism spectrum disorders (ASD) are characterized by deficits in language...

    Jing Zhang, Fang Cai, ... Jia-Da Li in Signal Transduction and Targeted Therapy
    Article Open access 05 June 2023
  5. The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19

    Individuals with Alzheimer’s disease and other neurodegenerative diseases have been exposed to excess risk by the COVID-19 pandemic. COVID-19’s main...

    Seda Sirin, Serap Nigdelioglu Dolanbay, Belma Aslim in Journal of Neural Transmission
    Article 16 April 2022
  6. Notch signaling pathway: a new target for neuropathic pain therapy

    The Notch gene, a highly evolutionarily conserved gene, was discovered approximately 110 years ago and has been found to play a crucial role in the...

    Yan Zhang, Tingting Wang, ... Yan Zhang in The Journal of Headache and Pain
    Article Open access 15 July 2023
  7. Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy

    Introduction

    Alzheimer’s disease is a neurocognitive disorder that affects elderly people by slowly impaired cognition, dementia, and gets worse with...

    Devika Jadhav, Nikita Saraswat, ... Devendra Shirode in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 11 January 2024
  8. Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder leading to loss of cognitive abilities and ultimately, death. With no cure...

    Helena Targa Dias Anastacio, Natalie Matosin, Lezanne Ooi in Translational Psychiatry
    Article Open access 22 June 2022
  9. FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation

    The role of fibroblast growth factor receptor 2 (FGFR2), an important mediator of stromal paracrine and autocrine signals, in mammary gland...

    Kamil Mieczkowski, Marta Popeda, ... Kamila Kitowska in Journal of Mammary Gland Biology and Neoplasia
    Article Open access 16 May 2023
  10. The Amyloid-β Pathway in Alzheimer’s Disease

    Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the center of Alzheimer’s disease (AD) pathophysiology. While the...

    Harald Hampel, John Hardy, ... Andrea Vergallo in Molecular Psychiatry
    Article Open access 30 August 2021
  11. Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology

    The apolipoprotein E4 ( APOE4 ) genotype is one of the strongest genetic risk factors for Alzheimer’s disease (AD), and is generally believed to cause...

    Shichao Huang, Zhen Zhang, ... Gang Pei in Signal Transduction and Targeted Therapy
    Article Open access 13 June 2022
  12. Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders

    Ubiquitination is a fundamental posttranslational protein modification that regulates diverse biological processes, including those in the CNS....

    Alexis Zajicek, Wei-Dong Yao in Molecular Psychiatry
    Article 24 July 2020
  13. The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells

    Fluorizoline is a prohibitin-binding compound that triggers apoptosis in several cell lines from murine and human origin, as well as in primary cells...

    Sonia Núñez-Vázquez, José Saura-Esteller, ... Joan Gil in Oncogenesis
    Article Open access 27 September 2021
  14. Hippocampal delivery of neurotrophic factor-α1/carboxypeptidase E gene prevents neurodegeneration, amyloidosis, memory loss in Alzheimer’s Disease male mice

    Alzheimer’s Disease (AD) is a prevalent neurodegenerative disease characterized by tau hyperphosphorylation, Aβ1-42 aggregation and cognitive...

    Lan Xiao, Xuyu Yang, ... Y. Peng Loh in Molecular Psychiatry
    Article Open access 28 June 2023
  15. Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

    Neurological diseases (NDs) are one of the leading causes of disability and the second leading cause of death globally. Among these stroke,...

    Madhumitha Katta, Blessy Aksa Mathew, ... Anjana Munshi in Neurological Sciences
    Article 06 September 2022
  16. The Development of Pharmacological Therapies for Alzheimer’s Disease

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that currently has no cure. The aged population is growing globally, creating an...

    Ping Lin, Junyu Sun, ... Jianqun Gao in Neurology and Therapy
    Article Open access 16 September 2021
  17. Abelmoschus esculentus subfractions attenuate Aβ and tau by regulating DPP-4 and insulin resistance signals

    Background

    Insulin resistance could be associated with the development of Alzheimer disease (AD). The neuropathological hallmarks of AD are beta...

    Chien-Ning Huang, Chau-Jong Wang, ... Chiung-Huei Peng in BMC Complementary Medicine and Therapies
    Article Open access 02 December 2020
  18. The puzzle of preserved cognition in the oldest old

    Although epidemiological studies predict an exponential increase in the prevalence of dementia with age, recent studies have demonstrated that the...

    Orso Bugiani in Neurological Sciences
    Article 12 November 2019
  19. Synaptic degeneration in Alzheimer disease

    Alzheimer disease (AD) is characterized by progressive cognitive decline in older individuals accompanied by the presence of two pathological protein...

    Makis Tzioras, Robert I. McGeachan, ... Tara L. Spires-Jones in Nature Reviews Neurology
    Article 13 December 2022
  20. Alzheimer-related genes show accelerated evolution

    Alzheimerʼs disease (AD) is a neurodegenerative disorder of unknown cause with complex genetic and environmental traits. While AD is extremely...

    Anne Nitsche, Christian Arnold, ... Thomas Arendt in Molecular Psychiatry
    Article Open access 13 March 2020
Did you find what you were looking for? Share feedback.